ArticleRespiratory research2012

Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.

Stacey L Tannheimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.